USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low After Earnings Miss

USANA Health Sciences, Inc. (NYSE:USNA)’s share price hit a new 52-week low during trading on Wednesday following a dissappointing earnings announcement. The stock traded as low as $40.51 and last traded at $44.78, with a volume of 14278 shares traded. The stock had previously closed at $45.96.

The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). The business had revenue of $212.87 million during the quarter, compared to analyst estimates of $218.64 million. USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.26%. During the same period last year, the business earned $0.89 EPS.

Analyst Ratings Changes

Several research firms recently commented on USNA. DA Davidson cut their target price on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, insider Paul A. Jones sold 2,714 shares of the stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $48.66, for a total value of $132,063.24. Following the transaction, the insider now owns 6,266 shares of the company’s stock, valued at $304,903.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other USANA Health Sciences news, CFO G Doug Iiekking sold 5,198 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Paul A. Jones sold 2,714 shares of the stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $48.66, for a total value of $132,063.24. Following the completion of the sale, the insider now owns 6,266 shares of the company’s stock, valued at $304,903.56. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 31,591 shares of company stock valued at $1,458,098. 0.33% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. CWM LLC grew its holdings in shares of USANA Health Sciences by 21.8% during the first quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares in the last quarter. New York State Common Retirement Fund boosted its position in USANA Health Sciences by 1.2% during the fourth quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock valued at $1,313,000 after purchasing an additional 279 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after purchasing an additional 494 shares during the last quarter. Strs Ohio boosted its position in USANA Health Sciences by 9.2% during the fourth quarter. Strs Ohio now owns 11,900 shares of the company’s stock valued at $637,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Quest Partners LLC acquired a new position in USANA Health Sciences during the fourth quarter valued at approximately $66,000. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Price Performance

The firm has a 50-day moving average of $46.27 and a 200 day moving average of $47.07. The stock has a market capitalization of $797.05 million, a price-to-earnings ratio of 13.03, a PEG ratio of 1.38 and a beta of 0.90.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.